Global Antibiotics Market Size study, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors) Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, and 7-ACA) and Regional Forecasts 2021-2027

  • Product Code:
    RP-ID-10347675
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Global Antibiotics Market is valued approximately USD 40.85 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.6 % over the forecast period 2021-2027. Antibiotics are the anti-microbial that destroy or slows down the growth of bacteria. Antibiotics are available in different forms like pills, capsules, syrups or injections. The increasing investments in research and development of new antibiotic drugs, increasing growth in the incidences of infection and chronic diseases and constant support from the governments for the development of antibacterial drugs have been driving the global market across the forecast period. There have been continuous efforts of pharmaceutical companies in development of new antibiotics which are more susceptible in nature. According to a report published by Proceedings of the National Academy of Science (PNAS), the consumption rate of antibiotics increased by 39% during the period of 2000-2015, whichis further expected to increase by 200% by 2030. As per the report of World Health Organization (WHO), around 10 million cases of tuberculosis were diagnosed in 2019, leading to increased consumption of antibiotics. However, strict government regulations for the approval of new medicines and certain side effects of antibiotics can hamper the growth of the market over the forecast period of 2021-2027. Whereas, prolonged increase in the demand of antibiotics is likely to increase the market growth during the forecast period.

The regional analysis of global Natural Extracts market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific holds the largest market share. This is mainly because of an increase in the number of prescriptions of antibiotics as well as the larger population in the region. Whereas, North America is also expected to project remarkable growth over the upcoming period 2021-2027. Factors such as the availability of many pharmaceutical manufacturers and improving healthcare infrastructure would help North America to outpace the Antibiotics Market.

Major market player included in this report are:
Allergan (AbbVie Inc.)
Merck & Co., Inc
Cumberland Pharmaceuticals, Inc.
GlaxoSmithKline plc
Novartis AG
Melinta Therapeutics
Teva Pharmaceutical Industries Ltd.
Nabriva Therapeutics plc
Mylan N.V.
Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

 

The detailed segments and sub-segment of the market are explained below:
By Action Mechanism:
Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others
By Drug Class:
Cephalosporin
Penicillin
Fluoroquinolone
Macrolide
Carbapenem
Aminoglycoside
Sulfonamide
7-ACA
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Antibiotics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Allergan (AbbVie Inc.)
Merck & Co., Inc
Cumberland Pharmaceuticals, Inc.
GlaxoSmithKline plc
Novartis AG
Melinta Therapeutics
Teva Pharmaceutical Industries Ltd.
Nabriva Therapeutics plc
Mylan N.V.
Abbott Laboratories

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->